DexCom
DXCM
YETI Holdings
YETI
Lantheus
LNTH
Collegium Pharmaceutical
COLL
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
AP Ampco-Pittsburgh
- 2.386
- +0.156+6.98%
Trading Jan 3 13:06 ET
47.94MMarket Cap-1.05P/E (TTM)
2.386High2.170Low17.82KVolume2.260Open2.230Pre Close40.34KTurnover0.12%Turnover RatioLossP/E (Static)20.09MShares2.80052wk High0.78P/B35.45MFloat Cap0.74052wk Low--Dividend TTM14.86MShs Float39.206Historical High--Div YieldTTM9.66%Amplitude0.740Historical Low2.264Avg Price1Lot Size
Ampco-Pittsburgh Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 452.45%11.36M | -95.84%-5.32M | 203.28%4.54M | 86.45%-3.69M | 197.62%6.64M | -222.60%-3.22M | 59.86%-2.71M | 73.01%-4.39M | -71.49%-27.21M | 40.68%-6.8M |
| Net income from continuing operations | ---- | ---- | ---- | -1,057.76%-38.12M | ---- | ---- | ---- | ---- | 220.61%3.98M | ---- |
| Operating gains losses | ---- | ---- | ---- | 29.63%-6.54M | ---- | ---- | ---- | ---- | -24.12%-9.3M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 1.53%17.67M | ---- | ---- | ---- | ---- | -2.62%17.41M | ---- |
| Deferred tax | ---- | ---- | ---- | -733.33%-2.96M | ---- | ---- | ---- | ---- | -64.11%468K | ---- |
| Other non cash items | ---- | ---- | ---- | 1,510.86%41.69M | ---- | ---- | ---- | ---- | -140.37%-2.96M | ---- |
| Change In working capital | ---- | ---- | ---- | 51.72%-17.51M | ---- | ---- | ---- | ---- | -0.15%-36.26M | ---- |
| -Change in receivables | ---- | ---- | ---- | 895.97%7.31M | ---- | ---- | ---- | ---- | -118.20%-918K | ---- |
| -Change in inventory | ---- | ---- | ---- | 92.17%-1.4M | ---- | ---- | ---- | ---- | 35.18%-17.9M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -166.40%-3.62M | ---- | ---- | ---- | ---- | -72.27%5.45M | ---- |
| -Change in other current assets | ---- | ---- | ---- | 119.33%762K | ---- | ---- | ---- | ---- | 33.37%-3.94M | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | -8.50%-20.56M | ---- | ---- | ---- | ---- | 30.75%-18.95M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 452.45%11.36M | -95.84%-5.32M | 203.28%4.54M | 86.45%-3.69M | 197.62%6.64M | -222.60%-3.22M | 59.86%-2.71M | 73.01%-4.39M | -71.49%-27.21M | 40.68%-6.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 42.17%-2.29M | 75.42%-1.53M | 15.25%-2.85M | -20.71%-19.69M | -62.71%-6.17M | 31.70%-3.96M | -82.71%-6.2M | -0.81%-3.36M | -10.68%-16.31M | -18.02%-3.79M |
| Net PPE purchase and sale | 28.97%-2.93M | 58.19%-2.66M | 19.13%-2.84M | -21.89%-20.32M | -72.00%-6.31M | 32.72%-4.13M | -84.13%-6.37M | -3.06%-3.51M | -11.09%-16.67M | -12.13%-3.67M |
| Net investment purchase and sale | -7.47%161K | 98.80%330K | -105.30%-8K | 74.45%635K | 220.00%144K | -49.71%174K | 159.38%166K | 104.05%151K | 33.82%364K | -300.00%-120K |
| Net other investing changes | --485K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-1K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 42.17%-2.29M | 75.42%-1.53M | 15.25%-2.85M | -20.71%-19.69M | -62.71%-6.17M | 31.70%-3.96M | -82.71%-6.2M | -0.81%-3.36M | -10.68%-16.31M | -18.02%-3.79M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -236.90%-5.37M | -68.61%3.89M | -59.42%2.03M | -49.07%21.69M | -94.54%365K | -53.39%3.92M | 10.06%12.41M | -69.20%5M | 74.52%42.59M | -47.79%6.68M |
| Net issuance payments of debt | -425.54%-4.25M | -73.14%2.2M | -59.42%2.03M | -68.75%11.36M | -172.36%-3.14M | -71.01%1.3M | -27.26%8.2M | -69.20%5M | 68.42%36.34M | -66.04%4.35M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -94.17%193K | ---- |
| Net other financing activities | -142.83%-1.12M | ---- | ---- | 70.73%10.33M | 63.90%3.51M | --2.62M | ---- | ---- | 1,347.63%6.05M | --2.14M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -236.90%-5.37M | -68.61%3.89M | -59.42%2.03M | -49.07%21.69M | -94.54%365K | -53.39%3.92M | 10.06%12.41M | -69.20%5M | 74.52%42.59M | -47.79%6.68M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.71%7.89M | 78.28%10.83M | -16.59%7.29M | -15.50%8.74M | -50.21%6.07M | 28.53%9.48M | -10.48%6.07M | -15.50%8.74M | -38.62%10.34M | -0.50%12.19M |
| Current changes in cash | 213.69%3.7M | -184.44%-2.95M | 235.20%3.72M | -81.16%-1.68M | 121.35%836K | -162.12%-3.26M | 212.63%3.49M | 18.49%-2.75M | 85.01%-929K | -107.42%-3.92M |
| Effect of exchange rate changes | 268.71%248K | 110.23%9K | -296.63%-175K | 134.77%234K | -17.57%380K | 65.57%-147K | 83.36%-88K | 150.00%89K | -119.22%-673K | 1,873.08%461K |
| End cash Position | 95.12%11.84M | -16.71%7.89M | 78.28%10.83M | -16.59%7.29M | -16.59%7.29M | -50.21%6.07M | 28.53%9.48M | -10.48%6.07M | -15.50%8.74M | -15.50%8.74M |
| Free cash flow | 214.58%8.42M | 12.06%-7.99M | 121.15%1.7M | 45.02%-24.13M | 103.12%327K | -109.73%-7.35M | 11.16%-9.08M | 59.21%-8.03M | -41.14%-43.9M | 28.76%-10.49M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |